Literature DB >> 5834734

Antitumor activity and pharmacologic disposition of cytosine arabinoside (NSC-63878).

R L Dixon, R H Adamson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 5834734

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN: 0069-0112


× No keyword cloud information.
  6 in total

1.  Herpesvirus hominis infection in newborn mice: comparison of the therapeutic efficacy of 1-beta-D-arabinofuranosylcytosine and 9-beta-D-arabinofuranosyladenine.

Authors:  E R Kern; J C Overall; L A Glasgow
Journal:  Antimicrob Agents Chemother       Date:  1975-05       Impact factor: 5.191

2.  Effect of cytosine arabinoside, adenine arabinoside, tilorone, and rifamycin SV on multiplication of Herpesvirus saimiri in vitro.

Authors:  R H Adamson; D V Ablashi; G R Armstrong; N W Ellmore
Journal:  Antimicrob Agents Chemother       Date:  1972-01       Impact factor: 5.191

3.  Assessment of cytosine arabinoside as an antiviral agent in humans.

Authors:  C B Lauter; E J Bailey; A M Lerner
Journal:  Antimicrob Agents Chemother       Date:  1974-11       Impact factor: 5.191

4.  Studies on the mechanism by which indomethacin increases the anticancer effect of methotrexate.

Authors:  A Bennett; J D Gaffen; P B Melhuish; I F Stamford
Journal:  Br J Pharmacol       Date:  1987-05       Impact factor: 8.739

5.  Effect of asparaginase on cell membranes of sensitive and resistant mouse lymphoma cells.

Authors:  E G Ankel; J Zirneski; B J Ring; J S Holcenberg
Journal:  In Vitro       Date:  1984-05

6.  Interaction of human serum albumin with anticancer agents in vitro.

Authors:  I Takahashi; T Ohnuma; S Kavy; S Bhardwaj; J F Holland
Journal:  Br J Cancer       Date:  1980-04       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.